| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |